Platelet-activating_factor_(PAF)_stimulates_the_production_of_PAF_acetylhydrolase_by_the_human_hepatoma_cell_line,_HepG2._The_human_hepatoma_cell_line,_HepG2,_secreted_an_activity_that_degrades_platelet-activating_factor_(PAF)_by_the_hydrolysis_of_the_sn-2_acetyl_group._This_activity_was_Ca++_independent,_inhibited_by_diisopropylfluorophosphate_but_not_by_p-bromophenacyl_bromide,_and_resistant_to_treatment_with_trypsin_or_pronase._Separation_of_HepG2-conditioned_medium_by_gel_filtration_disclosed_that_the_activity_was_associated_with_lipoproteins._An_antiserum_against_PAF_acetylhydrolase_immunoprecipitated_this_activity._It_was_not_recognized_by_an_antibody_against_lecithin:cholesterol_acyltransferase_(LCAT),_which_also_is_secreted_by_HepG2_cells._Therefore_the_phospholipase_A2_activity_of_LCAT_was_excluded_as_a_source_of_the_observed_activity._PAF_added_to_the_culture_medium_stimulated_the_secretion_of_the_PAF-degrading_activity_by_HepG2_cells,_while_lyso-PAF_was_inactive._Maximal_stimulation_was_observed_with_5_ng/ml_PAF,_which_induced_a_fivefold_increase._The_presence_of_5_ng/ml_PAF,_enhanced_the_secretion_of_35Smethionine-labeled_PAF_acetylhydrolase_and_cycloheximide_inhibited_both_the_basal_and_PAF-stimulated_secretion_of_the_labeled_enzyme._We_conclude_that_HepG2_cells_produce_PAF_acetylhydrolase._The_liver_may_be_a_major_source_of_plasma_PAF_acetylhydrolase,_and_PAF_may_induce_the_production_of_its_inactivating_enzyme_by_the_liver.